208 related articles for article (PubMed ID: 11905737)
1. Pattern of malignant disorders in individuals with Down's syndrome.
Hasle H
Lancet Oncol; 2001 Jul; 2(7):429-36. PubMed ID: 11905737
[TBL] [Abstract][Full Text] [Related]
2. Risks of leukaemia and solid tumours in individuals with Down's syndrome.
Hasle H; Clemmensen IH; Mikkelsen M
Lancet; 2000 Jan; 355(9199):165-9. PubMed ID: 10675114
[TBL] [Abstract][Full Text] [Related]
3. [Occurrence of cancer in individuals with Down syndrome].
Hasle H; Clemmensen IH; Mikkelsen M
Ugeskr Laeger; 2000 Aug; 162(34):4535-9. PubMed ID: 10981221
[TBL] [Abstract][Full Text] [Related]
4. [Incidence of cancer in individuals with Down syndrome].
Hasle H; Clemmensen IH; Mikkelsen M
Tidsskr Nor Laegeforen; 2000 Oct; 120(24):2878-81. PubMed ID: 11143409
[TBL] [Abstract][Full Text] [Related]
5. Cancers and immune related diseases associated with Down's syndrome: a record linkage study.
Goldacre MJ; Wotton CJ; Seagroatt V; Yeates D
Arch Dis Child; 2004 Nov; 89(11):1014-7. PubMed ID: 15499053
[TBL] [Abstract][Full Text] [Related]
6. Acute leukaemia in children with Down syndrome: a population-based Nordic study.
Zeller B; Gustafsson G; Forestier E; Abrahamsson J; Clausen N; Heldrup J; Hovi L; Jonmundsson G; Lie SO; Glomstein A; Hasle H;
Br J Haematol; 2005 Mar; 128(6):797-804. PubMed ID: 15755283
[TBL] [Abstract][Full Text] [Related]
7. Down's syndrome and leukemia: mechanism of additional chromosomal abnormalities.
Goh K; Lee H; Miller G
Am J Ment Defic; 1978 May; 82(6):542-8. PubMed ID: 148844
[TBL] [Abstract][Full Text] [Related]
8. [Breast cancer in women with trisomy 21].
Satgé D; Sasco AJ; Pujol H; Rethoré MO
Bull Acad Natl Med; 2001; 185(7):1239-52; discussion 1252-4. PubMed ID: 11975321
[TBL] [Abstract][Full Text] [Related]
9. Down syndrome and acute lymphoblastic leukaemia.
Whitlock JA
Br J Haematol; 2006 Dec; 135(5):595-602. PubMed ID: 17054672
[TBL] [Abstract][Full Text] [Related]
10. The role of chromosome 21 in hematology and oncology.
Fonatsch C
Genes Chromosomes Cancer; 2010 Jun; 49(6):497-508. PubMed ID: 20232485
[TBL] [Abstract][Full Text] [Related]
11. Bone marrow transplantation for the treatment of haematological disorders in Down's syndrome: toxicity and outcome.
Rubin CM; Mick R; Johnson FL
Bone Marrow Transplant; 1996 Sep; 18(3):533-40. PubMed ID: 8879614
[TBL] [Abstract][Full Text] [Related]
12. Mutations of JAK2 in acute lymphoblastic leukaemias associated with Down's syndrome.
Bercovich D; Ganmore I; Scott LM; Wainreb G; Birger Y; Elimelech A; Shochat C; Cazzaniga G; Biondi A; Basso G; Cario G; Schrappe M; Stanulla M; Strehl S; Haas OA; Mann G; Binder V; Borkhardt A; Kempski H; Trka J; Bielorei B; Avigad S; Stark B; Smith O; Dastugue N; Bourquin JP; Tal NB; Green AR; Izraeli S
Lancet; 2008 Oct; 372(9648):1484-92. PubMed ID: 18805579
[TBL] [Abstract][Full Text] [Related]
13. [Down's syndrome and leukemia].
Bermúdez Cortés M; Verdeguer Miralles A; Jovaní Casano C; Cañete Nieto A; Fernández JM; Ferris Tortajada J; Castel Sánchez V
An Esp Pediatr; 1998 Jun; 48(6):593-8. PubMed ID: 9662842
[TBL] [Abstract][Full Text] [Related]
14. Trisomic dose of several chromosome 21 genes perturbs haematopoietic stem and progenitor cell differentiation in Down's syndrome.
De Vita S; Canzonetta C; Mulligan C; Delom F; Groet J; Baldo C; Vanes L; Dagna-Bricarelli F; Hoischen A; Veltman J; Fisher EM; Tybulewicz VL; Nizetic D
Oncogene; 2010 Nov; 29(46):6102-14. PubMed ID: 20697343
[TBL] [Abstract][Full Text] [Related]
15. A tumor profile in Down syndrome.
Satgé D; Sommelet D; Geneix A; Nishi M; Malet P; Vekemans M
Am J Med Genet; 1998 Jul; 78(3):207-16. PubMed ID: 9677053
[TBL] [Abstract][Full Text] [Related]
16. Leukaemogenesis in Down's syndrome.
Gericke GS; Hesseling PB; Brink S; Becker WB
S Afr Med J; 1977 Feb; 51(6):158-62. PubMed ID: 138950
[TBL] [Abstract][Full Text] [Related]
17. Myelodysplasia and acute myelogenous leukemia in Down's syndrome. A report of 40 children of the AML-BFM Study Group.
Creutzig U; Ritter J; Vormoor J; Ludwig WD; Niemeyer C; Reinisch I; Stollmann-Gibbels B; Zimmermann M; Harbott J
Leukemia; 1996 Nov; 10(11):1677-86. PubMed ID: 8892666
[TBL] [Abstract][Full Text] [Related]
18. Cancer incidence of persons with Down syndrome in Finland: a population-based study.
Patja K; Pukkala E; Sund R; Iivanainen M; Kaski M
Int J Cancer; 2006 Apr; 118(7):1769-72. PubMed ID: 16231334
[TBL] [Abstract][Full Text] [Related]
19. Unique clinical and biological features of leukemia in Down syndrome children.
Xavier AC; Ge Y; Taub J
Expert Rev Hematol; 2010 Apr; 3(2):175-86. PubMed ID: 21083461
[TBL] [Abstract][Full Text] [Related]
20. Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.
Chessells JM; Harrison G; Richards SM; Bailey CC; Hill FG; Gibson BE; Hann IM
Arch Dis Child; 2001 Oct; 85(4):321-5. PubMed ID: 11567943
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
